If you have researched laser hair removal with skin darker than about a Fitzpatrick IV, you have already been handed the answer: long-pulsed Nd:YAG, 1064 nanometers, with a cooling tip. It is the right answer. The physics is not controversial — a longer wavelength is absorbed less by the melanin sitting in your epidermis and penetrates deeper to reach the follicle, so more of the energy goes where it is supposed to and less of it cooks the surface on the way in.
That sentence is where most articles stop. Here is the part that comes next.
In the modeling of epidermal thermal risk at 1064 nm, the risk runs from 10.7 percent in Fitzpatrick type I skin to 55.0 percent in type VI.
At the safe wavelength. Correctly selected. The right machine, the right laser, the recommendation everybody gives — and the thermal risk to the epidermis at the deep end of the range is more than five times what it is at the pale end.
Now the caveat that belongs directly underneath a load-bearing number. That pair of figures comes from thermal modeling — a calculation of how much energy ends up in the epidermis at 1064 nm across the six types, not a tally of burns in a clinic. And I have not been able to put an author, a journal and a year on the modeling itself. It circulates in device literature and in review writing without a traceable primary paper behind it. So read the ratio as the finding and the decimal places as borrowed, and hold the whole thing more loosely than the randomized numbers further down this page.
Safer is a comparative. It was always a comparative. It compares 1064 to alexandrite and diode and intense pulsed light, all of which are worse, and it does not promise you anything in absolute terms. Somewhere between the journal and the consultation, the comparative quietly became a reassurance.
The Nd:YAG laser is safe for dark skin.
- Source
- Epidermal thermal risk modeling at 1064 nm across Fitzpatrick types
- Participants
- Modeled across skin types I–VI
- Measured
- The full Fitzpatrick range, with risk calculated per type
- Not measured
- Nothing — the finding is in the model. It is the reporting that truncates.
10.7% epidermal thermal risk at type I. 55.0% at type VI. The wavelength is genuinely the best available choice and the residual risk at the deep end is not small.
What the head-to-head trials actually found
Two randomized comparisons are worth having in your head when somebody offers you a package deal.
The British Journal of Dermatology published a randomized trial in Fitzpatrick IV to VI patients comparing Nd:YAG against intense pulsed light. Hair reduction: 79.4 percent with the Nd:YAG, 54.4 percent with IPL.
A 2025 randomized trial in the Indian Journal of Dermatology, Venereology and Leprology compared a diode laser against IPL: 74.15 percent versus 46.47 percent. And the burn rate on the IPL arm was roughly four times higher.
So IPL does about two-thirds of the job and produces several times the burns. It is also, reliably, the cheapest thing on the menu and the thing sold as a package of twelve.
The reason IPL keeps being offered to people it is wrong for is not clinical. IPL machines are cheaper to buy, cheaper to run, and can be operated by staff with less training. A clinic that has one is going to sell what it has — and in thirty-six states nobody regulates who that staff member is.
The complication nobody can explain to you
Paradoxical hypertrichosis is exactly what it sounds like: laser hair removal producing more hair, usually at the edges of the treated area, usually finer at first and then not. A pooled analysis across 9,733 patients put the rate at about 3 percent.
Three percent is not nothing when you have paid for six sessions to have less hair.
The part I find genuinely striking is what the same analysis says about who it happens to. There is insufficient data to link paradoxical hypertrichosis to skin type. It is widely assumed to concentrate in darker, hormonally-driven-hair populations — Mediterranean, Middle Eastern, South Asian — and that assumption is in a great deal of clinical writing, and the pooled evidence does not establish it.
So a person in exactly the group most likely to be warned about it cannot be told whether the warning applies, and a person outside that group may not be warned at all.
Three things to settle before anyone switches the machine on
Not a list of questions to read off a phone. Three things, and they are mostly about the person rather than the machine.
Which laser, by wavelength, and what else is in the room. A clinic with one IPL unit and a confident manner is going to treat you with an IPL unit. A clinic with a 1064 and an 810 and an alexandrite is choosing.
A test patch, somewhere you can live with, with a real gap before the full session. Not the same appointment. The burns and the pigment changes that matter do not declare themselves in twenty minutes, and a clinic that will not build in a fortnight is telling you how it manages risk.
And what the settings were. Written down, in your notes, so that if something goes wrong or goes brilliantly, the next practitioner has a starting point rather than a category. This is the bit almost nobody does and it is the single most useful thing you can take away from a session.
The reason the settings matter more than the badge on the machine is measured elsewhere: halving the density on a fractional laser cut the pigment complication by two thirds with no loss of result. That number is here.
Ask what happens if there is a burn — who sees you, how fast, at whose cost. The answer tells you more about the clinic than the equipment list does.
Evidence check: Moderate
Evidence level: two randomized comparisons support the device hierarchy; the paradoxical hypertrichosis literature explicitly states there is insufficient data to link it to skin type. The 1064 nm epidermal thermal risk modeling could not be traced to a named author, journal or year, and the 10.7 to 55.0 percent figures should be read accordingly.
Sources reviewed September 13, 2026: Epidermal thermal risk modeling at 1064 nm across Fitzpatrick types I–VI — quoted widely in device and review writing; no primary publication identified. Randomized controlled trial of Nd:YAG versus IPL in Fitzpatrick IV–VI patients, British Journal of Dermatology 2012. Randomized controlled trial of diode laser versus IPL, Indian Journal of Dermatology, Venereology and Leprology 2025. Pooled analysis of paradoxical hypertrichosis, 9,733 patients.
This article is educational and is not a substitute for care from someone who can look at your skin. Anything new, changing, painful or spreading should be assessed rather than researched.
